期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | Communications Medicine (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 0.0
50 ratings
Rate
Reputation 0.0 Influence 0.0 Speed 0.0 | ||||||||||||||||||||||||||||||||
期刊簡稱 | |||||||||||||||||||||||||||||||||
ISSN | 2730-664X | ||||||||||||||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 1.90%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | https://www.nature.com/commsmed/ | ||||||||||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||||||
出版商 | Nature Portfolio | ||||||||||||||||||||||||||||||||
主題領域 | MEDICINE, RESEARCH & EXPERIMENTAL | ||||||||||||||||||||||||||||||||
出版國/地區 | United Kingdom | ||||||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||||||
每年文章數 | 170每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 99.72% | ||||||||||||||||||||||||||||||||
OA Related Info![]() | APC: Yes( GBP2490; USD3490; EUR2890; ) APC waiver:Check Notes Other charges: No Keywords: medicine、public health、epidemiology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review、Anonymous peer review、Double anonymous peer review | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | |||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2730-664X%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 21 Weeks | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Communications Medicine] 的評論 | 撰寫評論 |
作者: 斯提芬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-05-09 15:07:18 評論於 The journal issued a statement saying that they have recently received a large number of submissions which has led to delays in the processing, and they are waiting for further updates. Stage Start Date Under Review 12th Mar 25 Submission 27th Feb 25 Manuscript Transferred 27th Feb 25 ![]() ![]() |
作者: 遇见心软审稿人 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2025-02-13 23:05:21 評論於 2.13 25 under review + decision made About a month. desk reject. No response to the message. Status is not updated. Maybe everyone is busy with submissions lately. Editors are busy, understandable. ![]() ![]() |
作者: 遇见心软审稿人 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-11 00:02:09 評論於 By the way, he actually said it takes 8 days from submission to the first editorial decision (median). Haha. ![]() ![]() |
作者: 遇见心软审稿人 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-10 23:58:11 評論於 The speed is worrying. 22 days! Do you know how I survived these 22 days? When I saw that his stage had been on submission for 16 days, I couldn't resist and sent a reminder, but there was no response. However, I noticed that the external editor on the interface has been assigned. So, let's wait a little longer. It seems like there are many people submitting at the moment... 1.26 25 Submission 2.10 25 Submission ![]() ![]() |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us